Ignite Creation Date:
2025-12-24 @ 4:23 PM
Ignite Modification Date:
2025-12-27 @ 9:08 PM
Study NCT ID:
NCT00245466
Status:
TERMINATED
Last Update Posted:
2011-05-20
First Post:
2005-10-26
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study Investigating the Long-Term Safety and Tolerability of Repeated Doses of Degarelix in Prostate Cancer Patients
Sponsor:
Ferring Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2001-10
Start Date Type:
None
Primary Completion Date:
2006-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2006-03
Completion Date Type:
ACTUAL
First Submit Date:
2005-10-26
First Submit QC Date:
None
Study First Post Date:
2005-10-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2009-01-22
Results First Submit QC Date:
None
Results First Post Date:
2009-06-11
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2011-05-18
Last Update Post Date:
2011-05-20
Last Update Post Date Type:
ESTIMATED